Liquiritigenin suppresses osteoclastogenesis via multi-target mechanisms involving NF-κB/PI3K-AKT signaling pathways and metabolic reprogramming
Fields of Study & Subjects
Bone Metabolism and Diseases
Bone health and osteoporosis research
Pharmacological Effects of Natural Compounds
Publication details
- Journal / source
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Volume
- 246
- Pages
- 117678–117678
- Publication date
- 6 January 2026
- Language
- EN